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PART II - APPENDIX




70 ° Tilt Tolerance
Hemodynamic Alterations Resultant from 70 ° Passive Tilt -
Control Group
H=muuyn=m_u _.L'.-ULaLS-uZzS Resultant from 70 ° Passive Tilt -
9-(_-f luor ohydr oc or tisone Group
Brachial Artery Pulse Pressure - Control Group
Brachial Artery Pulse Pressure 9-_-fluorohydrocortisone
Group
Hemodynamic Response to 70 ° Tilt - Control vs. 9-_ _
fluorohydrocortisone Group
Hemodynamic Response to 70 ° Tilt - Combined Data of
All Subjects
Cardiac Output Response to 70 ° Tilt Control Group
Cardiac Output Response to 70 ° Tilt
cortisone Group
9-_- fluorohydro-
Comparison of Cardiac Output and Central Blood Volume
Changes During 70 ° Tilt
Percentage of Subjects Demonstrating Vasomotor Wave
Activity
Wave
Amplitude of Brachial Artery Pressure Variation Due
to Vasomotor Wave Activity
Heart Rate Variation Due to Vasomotor Wave Activity
Hemodynamic Response to 50W Exercise Control Group






Hemodynamic Response to 50W Exercise - 9-_-fluoro-
hydrocortisone vs. Control Group
Hemodynamic Response to 50W Exercise - Combined Data
of All Subjects
Left Ventricular Work- At Rest and 50W Exercise
Table 23: Oxygen Consumption - At Rest and 50W Exercise













Ventilatory Equivalent - At Rest and 50W Exercise
Exercise Factor - At Rest and 50W Exercise
Tyramine Stimulation Test - Maximum Rise in Arterial
Systolic Pressure
Total Blood Volume - Control Group
Total Blood Volume - 9-_-fluorohydrocortis0ne Group
Plasma Volume - Control Group
Plasma Volum& - 9-_-fluorohydrocortisone Group
Red Cell Volume - Control Group
•Red Cell Volume - 9f_-fluorohydrocortisone Group





Fluid Balance Data - 9-_-fluorohydrocortisone Group
/"
Fluid Balance Summary - Control Group
Fluid Balance Summary - 9-_-fluorohydrocortisone Group
Fluid Balance Comparison -Control Group vs. 9-_ -





Electrolyte Content of Formula" Diets
Sodium Balance Data - Control Group
Sodium Balance Data - 9-(7-fluorohydrocortisone Group




























Average 24-Hour Sodium Balance
Potassium Balance Data - Control Group
Potassium Balance Data - 9-_-fluorohydrocortisone Group
Average 24-Hour Urine Potassium Excretion
Average 24-Hour Potassium Balance
Calcium Balance Data Control Group
Calcium Balance Data 9-C_-fluorohydr'ocortisone Group
Average 24-Hour Urinary Calcium
Average 24-Hour Calcium Balance
Magnesium. Balance Data - Control Group
Magnesium Balance Data - 9-_-fluorohydrocortisone Group
Average 24-Hour Urinary Magnesium
Average 24-Hour Magnesium Balance
Chloride Balance Data - control Group
Chloride Balance Data - 9-_-fluorohydrocortisone Group
Average 24-Hour Chloride Excretion
Phosphate Balance Data - Control Group
Phosphate Balance Data - 9-_-fluorohydrocortisone Group
Average 24-11our Phosphate Excretion
Urine Catecholamines - Control Group
Urine Catecholamines - 9-_-fluorohydrocortisone Group
Urine Norepinephrine Excretion
Urine Epinephrine Excretion
i7-Hydroxycorticosteroid Excretion - Control Group
17-Hydroxycorticosteroid Excretion - 9-_-fluorohydro-
cortisone Group
O Figure 9 :
Figure I0:
Figure II:
Mean Day to Day Sodium and Water Balance
Average 24-11our Sodium and Water Balance During
the Ambulatory and Bedrest Phases
Average 24-Hour Excretion of Various Electrolytes






Subject Height Drug Average BP
(Inches) Therapy Amb. B.R.
A 71 1/4 0 112/62 114/60















































































Height Drug Average BP
Subject (Inches) 111erapy Arab. B.R.
Duration of
Bedrest (days)
15 66 1/4 0 122/84
16 73 1/4 9-_ 122/68




18 63 1/2 9-_ 116/68 118/66 14
19 74 0 110/58 118/68 14
20 72 9-_
" X 72 0






















































Subject Day i Day I _ Day 15
2 75.05 74.68 -0.37 74.50 -0.18
5 60.25 59.93 -0.32 59.80 -0.13
7 67.85 67.16 -0.69 66.40 -0.76
9 88192 88.63 -0.29 88.38 -0.25
ii 68.25 67.65 -0.60 68.13 +0.45
14 86.55 85.99 -0.56 86.16 +0.17
16 70.31 70°95 •+0.64 71.43 +0.48
17 64.71 64.77 +0.06 64.84 +0.07
18 62.59 62.48 -0.ii 62.32 -0.16
20 70.46 70.56 +0.I0 71.34 +0.78






















Broke bedrest by leg elevation xl; constipation,
nausea, gas pains, backache during bedrest.
Frequently unable to void for urine close-out, required
urethral catheterization xl, constipation, backache
during bedrest, atrial fibrillation occurred on second
cardiac catheterization.
Chronic hepatitis developed renal calculus (calcium-
oxylate) post recumbency.
Phlebitis of arm, mild after catheterization. Headache
and backache during bedrest.





Mild phlebitis of arm post-catheterization. Startled
by firecracker Day 4 of bedrest and briefly assumed
a sitting position.
Epigastric burning, nausea, gas pains, constipation
and backache during bedrest.
Phlebitis of arm post-catheterization, mild nausea
and headache during bedrest.
Difficulty keeping arms down. Mild phlebitis and
headache during bedrest.
Acute cystitis and hematuria during late bedrest
(Temp. 102°).
Constipation and headache during bedrest.•
Acute tonsilitis (Temp _ax i00°), backache • and
headache during bedrest.
Acute pharyagitis (Temp Nax 102.6°), headache,
backache; gas pains during bedrest.
(


















Mild pharyagitis and U R I, difficulty keeping
arms down during bedrest_
Dysuria, epigastric burning, backache during B'R.
None
None
Unable to void for close-out of urine, on one
occasion during B.R. Constipation d_ring bedrest.
Constipation
Instrument failure and heart block duringpre-
recumbency catheterization - Study cancelled.
Broke bedrest on 9th day, study cancelled.
Study cancelled due to evidence of excessive




































































































Control 132/76 142/86 20/8 26/10
I - 1371104 29110
2 130/90 28/10
5 116/78 130/92 28/9
I0 93/61 131/98 22/8
15 - 123/87 26/10
18 - 106/65 20/10








































4 Control 119/65 123/69 27/9 23/7
1 129/80 137/90 12/4 7/0





Terminal 115/82 57/27 9/3 9/2







































2216 1714 68 80
21/9 20/7 85 126
21/9 17/7 97 126
21/9 19/3 I01 124
- 16/3 99 129
- 16/3 ii0 136
- 15/3 112 146



























70 ° Passive Tilt
Resistances (dynes sec.cm. -5)
Peripheral Pulmonary















1250 1260 35.16 33.90 936
36.46 39.40
977 1250 39.48 34.80 1327
_ 34.44
39.84 37.86
1391 1299 198 210




4 124 103 2000 1710 38.22 38.15 806 895 135 119
32.72
36.00
72 - 1310 1371 102







89 76 1152 II00 40.28 34.40 1062 1324 163 144
37,90 34.80
33.81 34.80
56 32 1060 790 35.76 34.38 1500 2312 186 241
37.23 32.91
36,08 31.44


































122/72 132/75 26/14 11/4
147/96 152/96 26/13 17/8
149/97 147/95 26/13 16/6
152/104 142/95 27/13 12/5
146/102 142/93 28/12 16/6
146/102 133/94 28/13 15/4
147/105 130/95 27/12 15/4
144/102 135/94 .28/11 14/4
20 20
60 81 3.93 6.39
68 99
66 i01
67 119 3,65 4.26
73 125
76 119



















































120/70 21/9 16/8 64 87
137/92 22/9 17/12 94 118
126/87 23/8 17/11 95 125
107/75 18/7 16/12 105 138
























65 77 6.68 5.66
84 105
89 109
92 113 5.82 4.33




*Right atrial mean pressure.
OTABLE 5
Page 2b
_emodynamic Alterations Resultant from
Control Group
70 ° Passive Tilt
-5
Stroke Volume C.B.V. DoF.P. Resistances (dynes sec.cm. )
Case
ml. ml. sec/min. _ Peripheral Pulmonary
No.






1026 1387 41.40 36.51
38.22 35.25
39.60 34.75
894 881 37.89 30.25
37.92 30.00
37.28 31.44




1837 1234 398 107
2586 2009 416 150
2461 1087 357 90
I0 60 55 979 1089 38.11 35.93 1748 1378 150 979
36.44 -
34.58 33.21
62 27 750 863 35.70 35.01 1429 2135 222 239
24 880 32.82 2139 290
35.52
24 791 34.62 2359 329
35.25 35.18
12 104 95 1678 1564 41.44 36.51 918 874 160 128
32.86
36.25 30.00
43 1200 32.70 32.40 1242 202
13 105 73 1482 1468 39.85 38.44 1090 1300 168
36°48 36.90
36.86 36.02
62 37 1246 1023 37.92 38.53 1553 2143 220
61 34 1234 1104 35.50 38.04 1570 2028 218
38.00 36.88










Hemodynamic Alterations Resultant from 70 ° Passive Tilt
Control Group
Pressures (mm Hg) Heart Rate
B.A. P.A. beats/min.















122/73 118/75 15/6 3
117/84 108/75 12/4 1
117/83 115/78 - 1













































17/7 89 73 8.09 6.48
15/8 117 114
15/8 121 126
14/7 121 134 5.66 4.87
10/4 122 141 5.50 4.67
17/6 130 141
14/4 127 147 5.33 3.83
16/7 135 148 :























from 70 ° Passive Tilt
Resistances (dynes sec.cm. -5)
Peripheral Pulmonary



































'880 1086 128 136
1399 1544 127 181
1338 1268 131 120








Hemodynamic Alterations Resultant from 70 ° Passive Tilt
9-_-Fluorohydrocortisone Group
)
Pressures (mm Hg) Heart Rate
B.A. P.A. beats/min.















112/72 115/69 18/9 15/6 79 89
128/91 131/86 14/6 15/8 116 124
114/81 124/79 15/7 14/9 93 124



















135/71 126/66 17/4 24/5 69 63
141/91 184/127 19/10 33/15 79 106
145/91 188/127 18/11 34/16 81 99
131/84 184/129 17/11 33/14 87 108
95/67 162/122 16/9 29/13 87 iii
167/125 29/13 112
158/125 28/13 125
















122/71 146/83 20/8 24/11 54 82
- 165/98 22/10 28/11 66 112
136/85 158/98 20/11 22/8 72 97
125/83 154/99 20/11 23/7 84 106
120/84 137/92 19/11 24/7 78 Ii0
119/85 138/96 20/12 22/5 80 112
127/87 139/96 21/12 23/7 80 108
















123/70 20/11 13/4 71 82
135/91 22/12 19/10 95 108
130/87 25/14 13/5 98 124
137/91 22/13 - 104 138
125/90 21/13 - 118 136
113/85 - - - 147
124/87 - - - 141











llemodynamic Alterations Resultant from 70 ° Passive Tilt
9-_-Fluor ohydr oc or tisone Group
Stroke Volume C.B.V. D.F.P. Resistances (dynes sec.cm. -5)
ml. ml. sec/min. _ Peripheral Pulmonary
Before After Before After Before After Before After Before After
O
9
57 63 827 I010 33.2
31.3
32.3
33 29 757 762 32.2
1708 1328 253 121












115 71 1309 845 1186 1668 196 225









25 621 3892 324
68 72 896 1007 1923 1727 304 237









43 50 622 971 2584 1597 398 222
86 85 1392 1247 1156 181 120


















Hemodynamic Alterations Resultant from 700 Passive Tilt
9-_-Fluorohyd roc or tisone Group
Pressures (mm Hg) Heart Rate
B.A. P.A. beats/rain.















132/71 140/80 29/12 5 76 75
152/95 132/80 33/11 - 87 iii
145/94 124/74 30/10 - 88 116
142/100 110/74 27/15 1 92 124
135/85 110/65 23/15 1 97 123
114/76 19/13 91
























27/8 55 63 6.52 6.47
28/13 70 93
26/13 72 96
27/13 72 98 7.04 6.14
24/12 77 102 6.89 4.45
25/12 77 ii0





















22/].1 19/9 56 51 4.96
17/6 18/8 82 86
16/7 17/8 88 89
18/6 17/8 90 I00
18/7 17/7 93 108 3.67
18/7 93
16/6 92 4.58






























21/11 5 55 56
19/11 3 63 68
19/10 0 64 69
18/10 -3 70 79
16/10 -3 72 86
17/10 70
16/10 70
















Alterations Resultant from 70 ° Passive Tilt
9-(_-Fluorohydroc or tis one Group
I
C.B.V. D.F.P. Resistances (dynes
ml. sec/min. Per ipher a i









1155 1429 38.6 38.5 1198 1346
39.1 38.9
39.8 37.0
1155 979 37.9 35.2 2004 1794











1292 1362 41.8 40.2 1184 1276 245 161
39.0 35.6
39.1 37.9
1255 1064 38.5 38.4 1329 1590 170 156
1125 838 40.0 38.6 1347 2157 174 252
39.2 38.6
1208 833 38.7 38.9 1368 2151 188 231
38.7 39.5
16 83 102 1403 1382 40.8 42.9 1492 1308
40.3 40.2
38.9 42.2
- 47 39.3 40.5
40 32 37.7 40.0
37.7
48 1195 36.4 1520
36.4 24.4
170 102
- 1113 - 1508 - 119









i000 1137 1902 1721
918 I000 1805 2381





















Pressures (ramfig) }leart Rate
B.A. P.A. beats/min.















121/64 130/66 24/12 16/5 58 62
120/75 14.2/87 18/10 16/8 79 92
110/75 136/88 17/10 20/8 75 91
114/75 137/90 17/10 21/13 83 98
115/71 120/84 18/12 17/8 80 104
107/64 86/53 17/11 12/8 91 ii0
110/71 16/8 96






20 Control 112/66 122/69 17/8
1 111/75 136/80 13/5





Terminal 69/35 ** 11/5











**No pressure recorded. Loss of vision and
t
i






Hemodynamic Alterations Resultant from 70 ° Passive Tilt























































1222 1573 116 182
2230 197
OTABLE 7






70 ° Tilt Duration (min)
i
1 2 5 I0 15 -18
-- 40 38 32.



















48 47 36 36 39 27














51 52 48 44 44 42
















43 46 .42 39 37 38
33 39 37 34 31 33
33 34 29
33 37 33 , 31
49 50 34 43
47 48 37 34




















BI_CHIAL ARTERY PULSE PRESSURE
9-_-FLUOROI_DROCORTISONE GROUP
70 ° Tilt Duration (min)
Supine
Rest I 2 5
Pre 40 37 33 22








50 54 47 28























51 39 36 34 40
60 55 45 42 •43
50 42 38












50 52 51 49 52











Pre 57 45 35 39 49 43
Post 64 55 48 47 36 33
Pre 46 36 40
Post 53 56 45 43
* Became hypotensive before 20 minutes.
** No pressure recorded. Loss of vision and dizziness


























HEMODYN3/_IC RESPONSE TO 70 ° TILT
Control vs 9-_-Fluorohydrocortisone Group
No. Studies Supine Rest Tilt f_
Control 8 3.21 2.93 -0.28
9-_ 7 2.80 2.48 -0.32
P 0.4 0.95
Control 8 2.89 2.47 -0.42
9-(_ 7 2.76 2.40 -0.36
P 0.7 0.995
I
Control 8 1270 998 -272
-o
9-5 7 1124 ' 980 -144
P 0. i 0.2
Control 8 1256 972 -284
9-5 7 1135 974 -161








Control 8 80 52 -36
9-(_ 7 83 54 -29
P 0.7 0.99
Control 8 72 36 -36







































































































































HEMODYNAMIC RESPONSE TO 70 ° TILT














































































































































HEMODYNAMIC RESPONSE TO 70 ° TILT
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@TABLE 13
COMPARISON OF CARDIAC OUTPUT AND
CENTRAL BLOOD VOLU_ CHANGES




5 Min. I0 Min. 18 Min.
-670 -i,010 -250
!
-213 - 299 -128
O
Post-Recumbency
C.O. -930 -1,690 -960
C.B.V. -227 475 -179





PERCENTAGE OF SUBJECTS DEMONSTRATING
VASOMOTOR WAVE ACTIVITY
Tilt
Supine 70 ° Tilt Termination
Stable 29% 100% 89%
Hypotensive 0.5% 89% 44%
Post-Recumbency
Stable 70% 89% 89%
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HEMODYNAMIC RESPONSE TO 50 W






































































































H_IODYN_IIC RESPONSE TO 50 W EXERCISE





























































































HEMODYNA_IIC RESPONSE TO 50 W EXERCISE
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* Comparison with Control Group data










1 2 6 Ii 15
5720 5463 5862 5273 5684
5470 4370 4774 5123 -
3990 3629 4473 4032 3420
4845 4655 4655 - 4617
5201 5676 5985 5819 6033
4988 4703 5149 5463 5006
5396 4845 4911 4679 5225
6073 - 5658 5751 5945
4969 4999 4103 5232 4860
4746 4476 4612 4076 4004
5788 5531 5227 - 6167
5199 4835 5037 5050 5096


































*95 % Confidence Limits










1 2 6 ii
5890 5558 5510 5558
6194 5700 5035 4940
4209 4133 4204 4489
4845 4608 4798 4988
5956 5386 6602 6241
5178 5866 5092 -
- 5338 5738 5520
5958 5352 4992 5234
3939 3943 4179 3913
3906 4106 4096 3716
5228 5048 4935 4895
5130 5005 5016 4949






















*95 % Confidence Limits

































































































*95 % Confidence Limits

























































































*95 % Confidence Limits




































*95 % Confidence Limits

























































































































2 6 ii 15
2147 2129 2147 2080
2148 1945 1909 1725
1519 1567 1649 -
1606 1717 1812 1902
2182 2675 2529 2506
2322 2064 - 1780
1910 2162' 2109 2112
1900 1860 2022 1818
1411 1557 1437 1357
1470 1466 1516 1543
1759 1693 1705 1684
1852 1894 1884 1821






*95 % Confidence Limits








SUBJECT 1 SUBJECT 3
Day Intake Output Balance Intake Output Balance
i 3290 2120 1170 3291 2420 871
2 2790 1485 1305 3041 2510 1402
3 3040 1890 1150 - -
4 2790 1600 1190 2791 2290 501
5 3150 1660 1490 2791 2030 761
i
6 3941 2470 1471 3511 2771 740
/'
7 3510 2182 13-28 3391 2384 1007

















































































































































































































































































































































































































































































































































































































































































































































































9-_- Fluor ohyd r ocor tis one Group










































































































































































































Balance Intake Output Balance
351 2905 2330 575
1151 2535 - _
151 2153 2000 153
31 2435 2340 95
561 2535 1930 605
91 6373 5775 598
ll71 3203 2390 813













































































































































































































































































































































































































































































































































































































































































20 3005 . 2663
Mean 2744 2677













































CONTROL GROUP VS 9-(7-FLUORO_PfDROCORTISONE GROUP
Average Daily Average Daily Average Daily
Intake (ml) Output (ml) Balance (ml)
Ambulant Bedrest Ambulant Bedrest Ambulant Becrest
2931 2816 2193 2377 738 439
+210 +221 +257 -+216 -+226 +104
J
!
2744 2677 2192 2353 552 324
+209 +234 +224 !268 -+ 84 + 74
<0.2 <0.5 <0.995 <0.99 <0.2 <0. i
*95% Confidence Limits






SUBJECT PRED ANAL PRED ANAL
B 121.4 * 94.2 *
C 115.1 114.9 74.2 84.4
1-7 121.4 * 94.2 *
/
8 114.9 113.2 70.8 70.1
9 114.9 115.0 70.0 74.2
I0 114.7 116.8 64.5 80.4
Ii 114.7 116.8 64.5 80.4
12 115.1 114.9 74.2 85.8
13 114.7 116.3 68.4 83.3
14 114.9 114.5 67.9 87.1
15 114.7 116.3 68.4 83.3
16 115.1 115.6 74".2 93.3
17 114.9 113.2 70.8 86.3
18 114.9 116.2 70.8 81.1
19 115.1 114.9 74.2 85.8

















































































































































































































































































































































































































































































































































































































































































Diet Other Urine Diet Other Urine
Day Intake Intake Output Balance Intake Intake Output Balance
i 116 94 22 115 58 57
2 116 79 37 115 38 57
3 116 79 37 115 72 43
4 " 116 94 22 ].15 72 43
5 116 94 22 115 98 -17
6 116 90 26 115 98 17
7 116 -. 54 62 115 107 8
Cumu la tire Unc orrec ted +228 +242















116 112 4 115 114 I
116 112 4 115 114 I
116 122 -6 115 115 0
116 122 -6 115 115 0
116 105 ii 115 92 23
116 105 Ii 115 92 23
116 i00 16 115 97 18
116 i00 16 I15 97 18
116 112 4 115 93 22
116 112 4 115 93 22
116 81 35 115 98 17
116 81 35 115 98 17
116 86 30 115 107 8











































































































































































































9-C_-Fluorohyd roc or tis one Group
SUBJECT 7
Other Urine Diet































































































































Diet Other Urine Diet
Day Intake Intake Output Balance Intake
I 117 78 39 115
2 117 74 43 115
3 117 77 40 115
4 117 ii0 7 115
5 115 95 22 115
6 117 75 42 115
/
7 117 -,93 24 115





























































_ 13 117 92 25 115 129 -14
:I 14 117 95 22 115 129 -14
!
:I Cumulative Uncorrected +120 +82
Balance Correctedw -160 -198
I *20 meq/day for extrarenal sodium loss included, /,.
TABLE 41
SODIUM BALAsNCE DATA











7 116 " 97













































































































































































































































































S.E.** + 7 -+ 9
p***
+18
*Comparison with ambulant value
**95% Confidence Limits




































*Comparison with ambulant value
**95% Confidence Limits


















Ambulant Bedres t A
20.7 -2.4 -23. I
32.4 9.3 -23.1
19.3 14.7 - 4.6


























































































- I " 78
-12 " 74
9 " 56






































































































Diet Urine Feca i
Intake Output Output Balance
94 66 Ii 17
" 78 ii 5
" - Ii -
" 71 17 6
" 81 17 4
" 88 17 -]_I































94 74 0 20
" 55 7 32
" 82 7 5
" 82 7 5
" 91 ii - 8
" 92 Ii - 9
" 82 Ii 1
" 83 13 - 2
" 78 13 3
" " 81 13 0
" 90 15 -II
" 95 15 -16
" 85 15 - 6





















































































































































Intake Output Output Balance
SUBJECT 13
Diet Urine ....Fecal








6 " 59 "






























































































































































































































































































































Intake Output Output Balance
SUBJECT 5
Diet Urine -Fecal











































































































































































.I O POTASSIUH BA!_\NCE DATA
i 9-C_-Fluor ohydr oc or tis one Group
i SUBJECT 7 " L " SUBJECT 9
I Ambulant Diet Urine Fecal Diet Urine Fecal-
I Day Intake Output Output Balance Intake Output Output Balance
1 94 92 13 -ii " 74 61 " 0 13
2 " 85 13 - 4 _ " 48 ii 15
i_ 3 " 86 13 - 5 " 45 Ii 18
I 4 " " 82 12 0 " 65 " Ii - 2
i " 5 " 84 12 , - 2 " 68 7 -- 7
A -" " 6 " 89 12 ' - 7 ,, 68 7 - 7
7 " 76 0 18 " 66 • 7 - 5
'_ Cumulative Balance -II " " " +25
Bedrest . ' .
i D_y 94 95 ....0 - i • 74 69 ' 13 - 8
I O "2 " " i00 0 - 6. .. ." 63 13 - 2
I 3 '" " 92 5 - 3 '" 71 13 -I0
i 4 ._ " 99' 5 -I0 "_ " 61 ' II 2
i 5 "" " 108 5 -19 " " 45 ii 18
i 6 ' " iii 7 -24 " 42 ii 21
_i 7 "" . , - 7 .- " " 67 . 9 " - 2
i 8 " 83 , 7 4 -" " . .64 9 I
I "" 9 " 85 ii - 2 " 56 9 9
I I0 ,, 62 . ii. " 21 ' " 63 9 2
I II ,, 92 II . - 9 " ,, . 64 ' 9 1
J 12 " " 88 16 "-i0 " " 75 9 '-I0
13 . " 93 16 -1"5 " " " 65 9 0












Intake Output Output Balance
SUBJECT 14
Diet Urine -Fecal













































































































































































































































































































































































































9-_-Fluorohydr ocor tis one Group
SUBJECT 18
Diet Urine Fecal




























































Intake Output Output Balance
86 56 14 16
" .56 14 16
" 56 14 16
" 59 29 - 2
" 59 29 - _2
" 64 0 22















































































* Comparison with Ambulant Value
** 95 _o Confidence Limits




































































































* Comparison with Ambulant Value
** 95 % Confidence Limits





















































Ambulant Diet Urine Fecal
Day Intake Output Output Balance
SUBJECT 3
Diet Urine Fecal
Intake Output Output Ba lance
1 91.60 7.11 84.49
2 " 4.93 98.15 -11.48
3 " 4.79 86.81
4 " 5o52 86.08
5 " 5.46 205.42 -119.28
6 " 6.37 85.23















Cumulative Balance +211.64 +164.47
Bedrest
Day ....
O i 91.60 7.25 43.78 40.57 91.60 2.88 88.72
2 " 5.84 85.76 " 2.15 114.68 -25.23
3 " 8.26 83.34 " 4.98 86.62
4 : " " 8.'13 322.62 -239.15 " 5.49 86.11
5 " 7.72 83.88 " 5.77 257.87 -172.04
6 " 10.49 81.11 " 6.29 85.31.
7 " 9.12 142.00 -59.52 " 4.41 87.19
8 " 6.22 85.38 " 4.99 220.32 -133.71
9 " 9,21 82.39 " 5.01 86.59
I0 " 11.09 264°92 -184.41 " 6.87 84.73
• II " 11.34 80.26 " 7.70 172.32 -88.42
12 " 10.29 81.31 " 5.94 85.66













































































































































































































































































































































































































































































































































































































































































































































































" 17.96 177.89 -104.25
" 17.82 73.78
,, 15.50 76.10
" 18.35 104.74 -31.49
" 20.53 71.07
,, 19.96 71.64








































































































































































































































































































































































































































































































































































































































































































* Comparison with Ambulant value
** 95 % Confidence Limits




























































































Comparison with Ambulant value
95 % Confidence Limits

































































































































































































































































































































































Ambulant Diet Urine Fecal
Day Intake Output Output
1 18,61 9.71
2 " 8.87
3 " 9.84 37.31
4 " 9.63
5 " 9.14








Balance Intake Ou£put Output Balance
8.90 16o71 10.86 5.85
9° 74 " i0.83 5.88
-28.54 " 11.56 5.15
8.98 " 11.06 5.65
9.47 " 10.62 6.09
I
- 5.56 " 11.36 22.03 -16.68
8.92 " 7.99 1.82 6.90
+11.91 +18.84
8.78 16.71 10.28 6.43
7.17 " 9.87 3.64 3.20
-36.75 " 10.59 6.12
3.99 " 10.13 6.58
5.47 " 9.69 17.95 -10.93
-96.18 " 9.92 6.79
7.62 " 10.70 6.01
8.99 " 10.22 6.08 .41
-48.74 " 10.38 6.33
8.62 " 10.66 6.05
7.88 " 10.64 15.97 - 9.90
8.85 " 9.96 6.75
-40.89 " 7.54 9.17


















4 _ " 14.44
5 " i0.20

























































































































































i 16.72 4.79 11.93
2 " 7.58 9.14
3 " 7.58 9.14
4 _ " 7.64 9.08
5 " 7.64 26.7 -17.62
6 " 6.90 9.82
7 " 6.90 9.82
8 " 7.68 25.4 -16.36
9 ,, 7.68 9.04
IO " 6.93 9.79
ii " 6.93 21.5 -11.71
12 ,, 8.22 8.50
13 " 8.22 17.47 - 8.97










" 9.28 IG. 98










" " 10.71 9.55
" 10.38 9.88








































9-_-Fluor ohydr ocor tisone Group
SUBJECT 2
Urine Fecal Diet




5.75 59.00 -40.75 "
6.28 17.72 ',
4.98 19.02 ,,































" 13.16 22.94 -12. I0
" 11.82 12.18
" 11.77 12.23




" 13.06 35.15 -24.21
" 13.72 10.28
', 12.85 ii. 15
" 13.54 10.46














































>[AGNE SlUM BALANCE DATA


















































































































































































































































































































>IAGNE SIUM BALANCE DATA


















































3.06 18.61 11.45 7.16
9.31 " 11.45 7.16
9.44 " 11.43 19.00 -11.82
-18.16 " 11.43 7.18
10.02 " 10.79 7.82
10.02 " 10.79 14.30 - 6.48
8.28 " 10.18 8.43
10.52 ,, 10.18 8.43
9.30 " 11.75 9.77 - 2.91
-16.30 " 11.75 6.86
8.98 " 11.68 6.93
8.98 " 11.68 6.93
-19.96 " 10.87 33.0 -25.26



















































11.08 " 8.18 28.42
11.74 " 7.52




















































Subject Ambulant Bedrest A p*
1 4.42 6.47 +2.05
3 4.49 4.09 - .40
4 10.48 9.47 -I.01
6 I0.58 12.12 +I. 54
8 9.49 11.33 +1.84
I0 10.61 I0.00 - .61
12 12.06 13.47 +1.41
13 8.20 8.61 + .41
15 5.71 7.21 +1.50
19 9.45 10.40 + .95
Mean 8.55 9.32 +0.77 0.60
S.E.** -+i.96 -+2.01
p***
* Comparison with Ambulant value
** 95 % Confidence Limits
*** Comparison with Control Group
9-_-FLUOROHYDROCORTISONE GROUP
Subject _Ambulant Bedrest _ p*
2 6.12 6.51 + .39
5 11.74 12.66 + .92
7 9.69 11.36 +1.67
9 10.63 9.21 -1.42
II 6.44 6.47 + .03
14 9.63 10.78 +1.15
16 10.34 9,93 - .41
17 11.36 11.16 - .20
18 8.25 8.77 + .52
20 8.36 8.34 - .02










1 7.19 17.51 +10.32
3 8.34 8.17 - .17
4 1.91 3.94 + 2.03
• 6 2.76 .28 - 2.48
8 1.70 10.48 + 8.78
i0 2.69 3.59 + .90
12 5.60 2.25 - 3.35
13 .26 4.48 + 4.22
15 8.20 3.00 - 5.20
19 1.86 2.28 + .42













14 I. 68 i. 57
16 2.30 1.68





















* Comparison with Ambulant value
** 95 % Confidence Limits























3 _- " 142
4 " 123
5 " " 104
6 _ 157" 136
7 " 83





















































































































































































































































Balance Intake Output Balance
53 116 91 25
45 " 87 29
4 " 86 30
- i " 85 31
-15 " 82 34
31 _ " 121 - 5





























" 130 - 14
" 124 - 8
" 89 27
+37

















































































































































































































































3 _ " 126
4 " 153





































































































































































































































































Balance Intake Output Balance
20 116 I01 15
31 " I01 15
26 " 64 52
20 " 64 52
31 ,, 65 51
67 " 65 51












































































































































































































Day Intake Output Balance
i 116 74 42
2 " 74 42
3 " 83 33
4 " 83 33
5 " 105 ii
6 " 105 II































































































































AVERAGE 24-HOUR CHLORIDE EXCRETION
(meq)
9-_-FLUOROHYDROCORTISONE GROUP
P* Subject Ambulant Bedrest p*
Mean Mean
i01 126 108 131
3 116 120 5 103 115

























13 92 106 17 85 97
15 85 102 18 83 97
19 " 80 98













* Comparison with Ambulant Value
** 95 % Confidence Limits










Day Intake Output Balance
i 1885 1482 403
2 " 1379 506
3 " 1350 535
4 " 1055 830
5 " 1107 778
6 " 1051 834





2 ..- " i19_
3 " 1279































































































































































































































































































































































































































































































































3 " " 1080
4 _-" " 1080
5 " 958





























































































































































































































































































































































































































































































































































































































































































































































































* Comparison with Ambulant Value
** 95 % Confidence Limits






































































Subject 1 Subject 3 Subject




32.48 22.80 26.40 18.37 24.27 18.84 20.08 •11.79
47.18 21.43 38.37 17.83 12.70 6.00 30.14 12.45
61.27 42.61 35.04 13.53 42.18 12.90 31.94 13.78
16.56 30.24 - - 35.16 11.27 32.15 8.96
19.72 29.89 20.01 8.15 28.76 16.59 26.13 17.79
23.27 39.83 23.79 14.57 26.93 13.71 23°82 10.58
40.66 34.19 26.76 6.76 33.03 26.99
35.14 16.15
32.60 17.81 32.07 13.67
*NE is abbreviation for norepinephrine.








































































































































































9-_-Fluor ohydr oc or tisone Group
Subject 5 Subject 7






17.06 7.74 19o29 12.08
22.34 7.93 27.52 14.44














































































Subject 14 Subject 16




9.16 7.66 35o 89 17.91
8.76 5.37 43.97 15.21
l
/





6.21 5,11 31.53 16.50
9.16 7.74
18.37 1.26 31o26 14,88
21.35 7.45 28.38 10.19
41.26 10.73 26.04
abbreviation




















































































Control Group 9-_-Fludrohydrocortisone Group
Week of Study* Subject Week of Study*
A B-I B-2 A B-I B-2
i 46.98 18.14 32.18 2 24.48 16.09 29.40
3 33.27 20.01 25.28 5 23.23 24.23 36.31
4 26.38 31.96 31.70 7 24.22 21.80 24.17
6 27.39 29.14 27.95 9 33.18 27.59 39.78
8 40.16 33.56 38.92 ii 26.93 19.27 22.52
10 28.71 27.39 27.83 14 15.46 7.69 26.99
12 55.64 42.67 52.89 16 37.52 31.53 28.56
13 35.62 34.26 39.18 17 37.79 30.65 28.65
15 36.38 35.00 35.49 18 36.84 30.12 32.37
19 37.98 29.60 37.10 20 35.38 29.85 33°05
Group 36.85 30.17 34.85 29.50 23.88 30.18
Mean
S.E.** +10.83 +8.84 +-5.70 +-5.50 +5.54 +-3.80
i_** O. 2 0.95 0. I0 0.98
P (Intergroup comparils_n_ 0.I0 0.I0 0.i0
O
• L
*Values represe--nt mean'results for the
first (B-l) and second (B-2)weeks of
. 2 ° - " _ i"
**95 % Confidence Limits
***Comparison with Ambulant Data











Subject Week of Study*
A B-I B-2
1 28.80 30.07 30.61 2 20.35 17.53 20.62
3 16.58 8.15 10.67 5 9.79 11.62 14.54
4 12.58 13.93 21.57 7 12.11 7.65 12.00
6 12.67 13.38 12.13
8 .12.13 10.56 8.02
i0 7.43 8_50 3.64
12 17.01 30.37 12.41
9 10.82 13.38 10.22
Ii 10.89 7.26 ii. II
14 8.41 6.43 6.48
16 15.56 16.50 12.70
13 18.90 18.97 14.80 17 16.04 5.45 12.35
15 10.93 16.98 11.29 18 16.60 14o82 17.30
19 11.67 7.60 10.60 20 11.47 9.50 8.05
Gr°up 14.87 15.85 13.57 13.20 II.01 11.30
Mean
S.E.** ±4.25 ±6.03 ±5.38 ±2.67 ±3.14 ±5.07
P*** 0.70 0.70 0.25 0.45
P(Intergroup Comparison) -_ 0.45 0.i0 0.50
* Values represent mean results for the ambulant week (A) and the
first (B-l) and second (B-2) weeks of bedrest.
** 95 % Confidence Limits
*** Comparison with Ambulant Data
O

























































































28.2 28°0 13.5 17.0
13.0" 4.3 8.0







15.5 15.5 9.5 9.5 14.5 14.5 8.5 8.5
13.5 13.5 12.0 12.0 16.0 16.0
19 22.5 22.5 21.5 21.5
*Sample obtained on Ahlbulant Day 1 after bedrest.












































I 146 124 122
3 117 124 89
/
4 120 120 117
6 142 135 131
8 167 144 122
**i0 125 119 -
12 171 182 168
13 167 144 192
!
*'15 112 - -









































*A and B refer to Ambulant and





































*A and B refer to Ambulant and






















































IA* IB* 12B IA
2 125 114 127 28.0
i
5 122 124 143 23 .5
/
7 ......154 131 139 25.6
9 146 143 173 21. i
**ii 144 - - 24. I
14 157 139 166 16.5
16 156 149 177 22. i
17 139 130 150 18.9
18 117 126 132 17.6
20 123 124 134 II. 6
138 131 149 20.5














*A and B refer to Ambulant and Bedrest Days
















9-(_-Fluorohydrocor t is one Group
Osmotic
IA* IB* 12B IA
2.15 1.97 2.28 -0.91
2.09 2.22 2.48 -0.82
!
2.23 2.10 2.22 -0.89
1.84 2.01 2.59 -0.22
2.20 - - -0.58
1.93 1.98 2.18 -0.95
1.77 2.22 1.76 -0.53
1.87 1.85 1.60 -0.83
i.86 2.05 1.53 -0.66
1.76 2.06 1.48 -0.19
1.94 2.05 2.01 -0.67















*A and B refer to Ambulant and Bedrest Days







































































*Results are expressed as follows:
Creatinine - mgm/24 hrs.

















































































































*Results are expressed as follows:
Creatinine - mgm/24 hrs.


































































































*Results are expressed as follows:
Creatinine - mgm/24 hrs.










































URINE CREATININE & OSMOLALITY*
Control Group













































*Results are expressed as follows:
Creatinine - mgm/24 hrs.

























































































*Results are expressed as follows:
Creatinine - mgm/24 hrs.






























URINE CREATININE & OSMOLALITY*






















*Results are expressed as follows:
Creatinine - mgm/24 hrs.





































































































































*Results are expressed as follows:
Creatinine - mgm/24 hrs.





URINE CREATININE & OSMOLALITY
9-_- Fluorohydrocor tisone Group
















































































*Results are expressed as follows:
Creatinine - mgm/24 hrs.

















URINE CREATININE & OSMOLALITY*































































*Results are expressed as follows:
Creatinine - mgm/24 hrs.





























































*Results are expressed as follows:
Creatinine - mgm/24 hrs.






























































_0 00_ ._ 00_




















































o o o e.o o 0J o co 0 ._
X _ H H H _ H_ H_
I I I I I I I I
._ _ o o_ o _ o _ _ I_





























































































































































































































_ o _o o o o _4_ o
I I I I I I I !
"2_






















SERUM CHOLESTEROL _ TRIGLYCERIDES
CHOLESTEROL TRIGLYCERIDES





2 1 A 238 137
I B 212 118
• 12 B 230 230
I A 225 94
1B 171 83







5 1 A 214.5 85












8 1 A 196 71








9 i A 284 119 --





*A symbolizes ambulant phase.













































12 B 230 90
I A 244 107
1B 244 103
12 B 288 96
1A 175 119
1B 170 114









































































































































































































_ Hemoglobin _ ,
= : _ Sedimentation. Rate
- Hematocrit
-- : Hemoglobin _




_ #_ Sedimentation Rate
_ .-_ - .... -__,
•18 -_.... WBC-"- ...............
t-'_-/Hematocrit
Hemoglobin
_ - =___-; _ ,









































































































































• , HYDROSTATIC PRESSURE EFFECTS OF GRA_/ITY
SUP/NE POSTURE
COMPRESSOR "" _1 "" .................................................. °11_
,H.?.,, U ........................: ...........:i .........J_




























































_. . . .. ..... .
Figure 2. The hemodynamic response to 70 ° passive foot-down










Figure 3 b. Brachial artery vasomotor Waves are present (BA).
A similar variation is seen in heart rate (HR).












• "m .e . . •
























• SUPINE _ 70 ° TILT
2-4 min. 8-10 min.
._EFORE BEDREST
• --" ......... AFTER BEDREST
terminal
2 rain. "
SUPINE ,, 70 ° TILT








Summary of brachial artery vasomotor wave frequency
and amplitude at rest and after various intervals of
" 70 ° tilt in stable and orthostatic intolerant subjects




0HEMODYNAMIC RESPONSE TO 50 WATT EXERCISE
0
SUPINE REST I 50 WATT EXERCISE
I













SUPINE REST I 50 WATT EXERCISE
I
161_ F_RIPHERAL VASCULAR RESISTANCE
T (Dynes-Sec.-Cm:S)









I 5"._ CONFIDENCE LIM/TS
-- BEFORE BEDREST
......... AFTER BEOREST
Figure 5. Hemodynamic response to 50 watt supine bicycle






























CONTROL GROUI _ 9-¢<-FLUOROHYDROCORTISONE GROUP
_ I'P<O,O011 .-rp <0.9-I





_." :;V_ .<C " -,. .... " :_÷.+.,._t
_;F ....
> _ _, _ "'_,_'.'>"
AMBULANT BEDREST BEDREST
I-5 Doy$ 11-14 Doys
I-"IPLASMA VOLUME








I-5 0o_= 11-14 D(I_s
Figure 8. Mean total blood volume, plasma volume and red cell
volume of the control and 9-_ groups at the stated































7 14 "-- I 7.1
BEDREST AMBUL ANT




Mean day to day sodium and water balance of the


































" Figure I0. Average 24-hour sodium and water balance during
































- _ P 0.6
...... P 0.95









Figure ii. Average 24-hour excretion of various electrolytes
during the ambulatory and bedrest phases of the
control and 9-_ group.
L
j:
%
I
